These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 616673)

  • 1. Inactivation of human interferon by body fluids.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1977; 35():443-8. PubMed ID: 616673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of body fluids on polynucleotide-induced fibroblast interferon and virus-induced leukocyte interferon.
    Cesario TC
    Proc Soc Exp Biol Med; 1977 Sep; 155(4):583-7. PubMed ID: 896807
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between body fluids, chemotherapeutic agents and interferon.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1981-1982; 41():259-62. PubMed ID: 6184812
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cell membrane in the antiviral effect of interferon.
    Pitha PM; Vengris VE; Reynolds FH
    J Supramol Struct; 1976; 4(4):467-73. PubMed ID: 778494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies of in vitro IFN induction by different polynucleotides in human cell culture systems].
    Glück B; Meister WV; Witkowski W; Stelzner A; Hoffmann S
    J Basic Microbiol; 1988; 28(8):501-7. PubMed ID: 2466978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of interferons.
    Sedmak JJ; Grossberg SE
    Tex Rep Biol Med; 1977; 35():198-204. PubMed ID: 29357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of IFN beta with human fibroblasts in monolayer cultures. Comparative studies of induction with virus (NDV) and synthetic polynucleotides (poly I - poly C).
    Frappa J; Trotemann P; Beaudry Y; Fontanges R
    Dev Biol Stand; 1981; 50():185-92. PubMed ID: 6176485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of human interferons: an overview.
    Mizrahi A
    Dev Biol Stand; 1983; 55():219-30. PubMed ID: 6203796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of interferons produced by peripheral blood mononuclear cells from healthy subjects in response to Corynebacterium parvum or poly I: poly C.
    Hertzog PJ; Cheetham BF; Sexton JL; Linnane AW
    Biochem Int; 1989 Dec; 19(6):1427-36. PubMed ID: 2483976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and production of human interferon with a continuous line of modifies fibroblasts.
    Tan YH
    Methods Enzymol; 1981; 78(Pt A):120-5. PubMed ID: 6173575
    [No Abstract]   [Full Text] [Related]  

  • 11. Human interferon and its inducers: clinical program overview at Roswell Park Memorial Institute.
    Carter WA; Horoszewicz JS
    Cancer Treat Rep; 1978 Nov; 62(11):1897-8. PubMed ID: 728908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of interferon in viral hepatitis B.
    Desmyter J
    Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production.
    Hersh EM; Reuben JM; Bogerd H; Rosenblum M; Bielski M; Mansell PW; Rios A; Newell GR; Sonnenfeld G
    Cancer Res; 1983 Mar; 43(3):1365-71. PubMed ID: 6186374
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification of human fibroblast interferon prepared from modified fibroblasts.
    Tan YH
    Methods Enzymol; 1981; 78(Pt A):422-30. PubMed ID: 6173624
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man.
    Strander H
    Tex Rep Biol Med; 1977; 35():429-35. PubMed ID: 358466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic properties and heterospecific antiviral activities of human leukocyte interferon species.
    Paucker K; Dalton BJ; Torma ET
    Adv Exp Med Biol; 1978; 110():75-84. PubMed ID: 83098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic properties of chick interferon; its antigenic relations with a substance extracted from uninfected egg allantoic fluid].
    German A; Quero AM; Poindron P
    Ann Inst Pasteur (Paris); 1971 Aug; 121(2):207-21. PubMed ID: 4329707
    [No Abstract]   [Full Text] [Related]  

  • 19. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
    Jankowski WJ; Davey MW; O'Malley JA; Sulkowski E; Carter WA
    J Virol; 1975 Nov; 16(5):1124-30. PubMed ID: 1185850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.